Einstein in the Media | U.S./Global

NBC News features Ekaterina Dadachova, Ph.D., and her focus on radioimmunotherapy. Preclinical research shows it has the potential to eradicate HIV. The research, which uses radioactive isotopes to target cells, tested radioimmunotherapy on human blood samples and a laboratory model of the blood-brain barrier constructed of human cells. Dr. Dadachova is professor of radiology and of microbiology & immunology and the Sylvia and Robert S. Olnick Faculty Scholar in Cancer Research. (Friday, December 06, 2013)

More coverage on this story | Dr. Dadachova's Profile


The Wall Street Journal highlights groundbreaking research by Steven Walkley, D.V.M., Ph.D., that has led to treatment options for the rare condition Niemann-Pick Type C. In a lengthy cover story covering at least six years of reporting, journalist Amy Marcus details the passion that drove Walkley to continue his research on the drug cyclodextrin – and explores how parents and scientists have joined forces to find more effective treatments. (Thursday, November 14, 2013)

See Multimedia Version of this Feature | More coverage on Dr. Walkley | Dr. Walkley's Profile


BBC News interviews Harry Ostrer, M.D., and The New York Times cites research by Gil Atzmon, Ph.D., in two articles about a new study on Jewish genetic history. The new study analyzed mitochondrial DNA, genetic information inherited through women, and found that at least 80 percent of Ashkenazi maternal ancestry hailed from Europe, not the Middle East, suggesting that many European Jewish communities were founded by men who married and converted local women. Dr. Ostrer is professor of pathology, of genetics and of pediatrics at Einstein and director of genetic and genomic testing at Montefiore Medical Center. Dr. Atzmon is associate professor of medicine and of genetics. (Wednesday, October 09, 2013)

More coverage on this story | More coverage on Dr. Ostrer | More coverage on Dr. Atzmon | Dr. Ostrer's Profile | Dr. Atzmon's Profile


NPR interviews Johanna Daily, M.D., about the new, modestly effective RTS,S malaria vaccine that reduced disease in children by 27-46 percent. Dr. Daily notes that while higher efficacy rates are desirable, malaria is a particularly challenging disease that researchers have struggled to prevent. She explains that each country that battles with malaria will have to choose how to spend their limited resources – on this vaccine, protective nets, community health workers or other options. Dr. Daily is associate professor of medicine and of microbiology & immunology. (Tuesday, October 08, 2013)

More coverage on Dr. Daily | Dr. Daily's Profile


CBSNews.com interviews Lou Weiss, M.D., M.P.H., about a new blood test that determines whether a person's respiratory illness is caused by virus or bacteria. Dr. Weiss explains that the test, which provides results in only 12 hours, has the potential to be extremely beneficial because it can help with diagnosis and prevent doctors from giving unnecessary antibiotics, which drives the growing problem of antibiotic resistance. Dr. Weiss is professor of pathology and of medicine at Einstein. (Tuesday, September 24, 2013)

More coverage on Dr. Weiss | Dr. Weiss' Profile


The New York Times' Science Times section interviews Jean Hébert, Ph.D., about his research featured in Science that found a link between hyperactivity and an inner ear defect in mice. Because the study was preliminary, Dr. Hébert cautions that parents should not start testing their hyperactive children for hearing loss. Dr. Hébert is professor in the Dominick P. Purpura Department of Neuroscience and of genetics. (Monday, September 09, 2013)

More coverage on this story | Dr. Hébert's Profile


The Wall Street Journal interviews Max O’Donnell, M.D., for a front-page story on a TB “hotbed” that developed in a South African prison. Dr. O’Donnell notes that poor monitoring and crowded conditions can result in the disease “spiraling out of control.” Dr. O’Donnell is assistant professor of medicine and of epidemiology & population health at Einstein. (Thursday, August 08, 2013)

Dr. O'Donnell's Profile


The New York Times interviews Adam Wollowick, M.D., about the dangers wearing heels may pose to the developing feet and ankles of children.  Despite their growing popularity and availability, Dr. Wollowick warns that because of their open growth plates, softer bones and still-developing coordination skills, children in heels and other elevated shoes are more susceptible to injury. Dr. Wollowick is assistant professor of orthopaedic surgery at Einstein.   (Thursday, August 01, 2013)

Dr. Wollowick's Profile


Methamphetamine users are more vulnerable to fungal lung infections according to new research by Luis Martinez, Ph.D., featured in The Los Angeles Times. Dr. Martinez and his colleagues found that the illicit drug weakened the blood-brain barrier, which facilitated cryptococcosis fungal infection and accelerated the progression of disease in mice. Dr. Martinez is adjunct clinical assistant professor of medicine at Einstein. (Thursday, August 01, 2013)

Dr. Martinez's Profile


NBCNews.com reports on new research by Thomas Rohan, M.D., Ph.D., and Geoffrey Kabat, Ph.D., that suggests taller postmenopausal woman are at greater risk of developing cancer. The study found a 13% increase in overall cancer risk for every increase of 10 centimeters (about 4 inches) in height. Dr. Rohan is chair and professor of epidemiology & population health and Dr. Kabat is a senior epidemiologist at Einstein. (Thursday, July 25, 2013)

More coverage on this story | Dr. Rohan's Profile


The Hill published an op-ed by Einstein's Dean, Allen M. Spiegel, M.D., and Montefiore President and CEO Steven Safyer, M.D., titled "Angelina Jolie, the Sequester, and Health in America." The authors argue that Ms. Jolie's decision to undergo a prophylactic mastectomy was made possible by two decades of research by inquisitive scientists on the BRCA1 and BRCA2 genes, much of it supported by the NIH. They assert that the funding cuts demanded by the sequester places this type of research in jeopardy. (Tuesday, June 25, 2013)

More coverage on Dr. Spiegel | Dr. Spiegel's Profile | Dr. Safyer's Profile | Dean's Page


Forbes interviews Jill Crandall, M.D., about resveratrol, an extract of red wine, and its potential to boost metabolism in humans. Dr. Crandall, who studies resveratrol’s effect on insulin sensitivity, notes that the research in humans is still too early and does not provide enough evidence to suggest that people take supplements. Dr. Crandall is associate professor of clinical medicine at Einstein and attending physician of endocrinology at Montefiore Medical Center. (Tuesday, June 25, 2013)

More coverage on Dr. Crandall | Dr. Crandall's Profile


CBS-TV interviews Robert Angert, M.D., and two first-year medical students at Einstein about the "cuddling" program they run in Montefiore's NICU. Students Jenny Wang and Caitlyn Williams share why they volunteer to hold the babies in the neonatal intensive care unit (NICU) and Dr. Angert explains how the babies benefit from the extra contact and care. Dr. Angert is assistant professor of pediatrics at Einstein and a neonatologist at Montefiore Medical Center. (Tuesday, June 25, 2013)

Dr. Angert's Profile


Medscape interviews Dr. Elizabeth Walker about her research that found targeted phone calls may help control diabetes in poor, underserved urban areas. The phone calls, which were made by health educators from the same community as the participants, provided counseling for medication adherence, exercise and diet. Dr. Walker is professor of medicine and epidemiology & population health. Dr. Walker is professor of medicine and epidemiology & population health. (Login required) (Tuesday, June 25, 2013)

More coverage on this story | Dr. Walker's Profile


The Wall Street Journal interviews Harry Ostrer, M.D., about an historic and unanimous Supreme Court ruling that determined human genes cannot be patented. Dr. Ostrer, one of the original plaintiffs in the case that centered on the BRCA1 and 2 genes, notes that the decision should help expand access to genetic testing and help reduce costs considerably. Dr. Ostrer is professor of pathology, of genetics and of pediatrics at Einstein and director of genetic and genomic testing at Montefiore Medical Center. (Friday, June 14, 2013)

More coverage on this story | More coverage on Dr. Ostrer | Dr. Ostrer's Profile

First Page | Previous Page | Page of 14 | Next Page | Last Page